Cargando…
Radiobiological Characterization of (64)CuCl(2) as a Simple Tool for Prostate Cancer Theranostics
(64)CuCl(2) has recently been proposed as a promising agent for prostate cancer (PCa) theranostics, based on preclinical studies in cellular and animal models, and on the increasing number of human studies documenting its use for PCa diagnosis. Nevertheless, the use of (64)CuCl(2) raises important r...
Autores principales: | Guerreiro, Joana Fernandes, Alves, Vítor, Abrunhosa, Antero José, Paulo, António, Gil, Octávia Monteiro, Mendes, Filipa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278521/ https://www.ncbi.nlm.nih.gov/pubmed/30423862 http://dx.doi.org/10.3390/molecules23112944 |
Ejemplares similares
-
Biokinetic and dosimetric aspects of (64)CuCl(2) in human prostate cancer: possible theranostic implications
por: Righi, Sergio, et al.
Publicado: (2018) -
Pilot Study of (64)CuCl(2) for PET Imaging of Inflammation
por: Jiang, Lei, et al.
Publicado: (2018) -
In vivo [(64)Cu]CuCl(2) PET imaging reveals activity of Dextran-Catechin on tumor copper homeostasis
por: Parmar, Arvind, et al.
Publicado: (2018) -
Synthesis-free PET imaging of brown adipose tissue and TSPO via combination of disulfiram and (64)CuCl(2)
por: Yang, Jing, et al.
Publicado: (2017) -
(64)CuCl(2) PET Imaging of 4T1-Related Allograft of Triple-Negative Breast Cancer in Mice
por: Latgé, Adrien, et al.
Publicado: (2022)